Contact Us
Global Personalized Medicine Biomarkers Market Report 2025

Personalized Medicine Biomarkers Global Market Report 2025 - By Biomarker Type (Genomic, Proteomics, Metabolic, Other Biomarker Types), By Disease Indication (Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, Other Indications), By Application (Early Detection Or Screening, Diagnosis, Treatment Selection, Monitoring), By End Use (Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Diagnostic Labs, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Personalized Medicine Biomarkers Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : May 2025 | Delivery Time: 2-3 business days Info | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Personalized Medicine Biomarkers Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Personalized Medicine Biomarkers Market?

Personalized medicine biomarkers are specific biological indicators that tailor medical treatments to individual patients based on their unique genetic, molecular, or physiological characteristics. These biomarkers can help predict how a patient will respond to a particular drug, enabling doctors to choose the most effective and safest treatment options.

The main types of biomarkers in personalized medicine are genomic, proteomic, metabolic, and others. Genomic biomarkers are specific genes or genetic mutations that help in understanding how diseases develop and progress in individuals. It is used for various disease indications, including oncology, neurology, diabetes, autoimmune diseases, cardiology, and others, for various applications, including early detection or screening, diagnosis, treatment selection, and monitoring. And it caters to various end users, including hospitals and clinics, pharmaceutical and biotechnology companies, diagnostic labs, and others.

Personalized Medicine Biomarkers Market Size and growth rate 2025 to 2029: Graph

What Is The Personalized Medicine Biomarkers Market Size 2025 And Growth Rate?

The personalized medicine biomarkers market size has grown rapidly in recent years. It will grow from $22.85 billion in 2024 to $26.98 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, rising adoption of companion diagnostics, growing investment in biomarker research, rising focus on early diagnosis and preventive healthcare, and regulatory support for biomarker-based therapies.

What Is The Personalized Medicine Biomarkers Market Growth Forecast?

The personalized medicine biomarkers market size is expected to see rapid growth in the next few years. It will grow to $51.53 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to expanding applications in precision oncology, increasing demand for targeted therapies, growing focus on early disease detection, growing consumer demand for personalized approaches, and supportive government policies and funding. Major trends in the forecast period include a multi-omics approach for biomarker identification, development of liquid biopsy-based biomarkers, increasing use of digital biomarkers, adoption of AI and machine learning in biomarker discovery, and expansion of real-world evidence in biomarker validation.

How Is The Personalized Medicine Biomarkers Market Segmented?

The personalized medicine biomarkers market covered in this report is segmented –

1) By Biomarker Type: Genomic, proteomics, Metabolic, Other Biomarker Types

2) By Disease Indication: Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, Other Indications

3) By Application: Early Detection Or Screening, Diagnosis, Treatment Selection, Monitoring

4) By End Use: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Diagnostic Labs, Other End Users

Subsegments:

1) By Genomic: Single Nucleotide Polymorphisms (SNPs), Copy Number Variations (CNVs), Gene Expression Biomarkers, Epigenetic Biomarkers

2) By Proteomics: Protein Expression Biomarkers, Post-Translational Modification (PTM) Biomarkers, Protein-Protein Interaction Biomarkers, Enzyme Activity Biomarkers

3) By Metabolic: Lipid Biomarkers, Amino Acid Biomarkers, Carbohydrate Biomarkers, Hormone Biomarkers

4) By Other Biomarker Types: Inflammatory Biomarkers, Microbiome Biomarkers, Autoantibody Biomarkers, Extracellular Vesicle Biomarkers

What Is Driving The Personalized Medicine Biomarkers Market? Rising Prevalence Of Chronic Diseases Driving Growth Of The Market Due To Increasing Need For Targeted Treatments And Precision Diagnostics

The growing prevalence of chronic diseases is expected to propel the growth of the personalized medicine biomarkers market going forward. Chronic diseases are long-term medical conditions that progress slowly and persist for a year or more, requiring ongoing medical attention or limiting daily activities. The growing prevalence of chronic diseases is due to unhealthy lifestyle choices, inferior diets, lack of physical activity, and high levels of stress. Personalized medicine biomarkers help tailor treatments for chronic diseases by identifying effective therapies, predicting disease progression, and minimizing adverse effects based on individual genetic and molecular profiles. For instance, in February 2024, according to the World Health Organization (WHO), a Switzerland-based health authority, by 2050, the number of new cancer cases is expected to surpass 35 million, representing a 77% increase from the estimated 20 million cases in 2022. Therefore, the growing prevalence of chronic diseases is driving the growth of the personalized medicine biomarkers market.

Who Are The Major Players In The Global Personalized Medicine Biomarkers Market?

Major companies operating in the personalized medicine biomarkers market are AbbVie Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Merck KGaA, GE Healthcare, Laboratory Corporation of America Holdings (LabCorp), Agilent Technologies Inc., Hologic Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., DH Life Sciences LLC, Myriad Genetics Inc., Guardant Health Inc., Cardiff Oncology Inc., 23andMe Inc., Coriell Life Sciences Inc.

What Are The Key Trends Of The Global Personalized Medicine Biomarkers Market? Regulatory Approvals Enhance Advancements In Personalized Medicine

Major companies operating in the personalized medicine biomarkers market are focusing on obtaining regulatory approvals to enhance the credibility of their products, expand their market presence, and improve patient outcomes. Regulatory approvals refer to the official authorization of health authorities, confirming that a medical product, treatment, or technology meets safety, efficacy, and quality standards for public use. For instance, in August 2024, Illumina, Inc., a US-based biotechnology company, received the Food and Drug Administration (FDA) approval for its cancer biomarker test and two companion diagnostics. The test uses next-generation sequencing (NGS) technology to identify genetic mutations in cancer cells, enabling clinicians to select the most suitable treatments based on individual biomarkers. This approval marks a significant advancement in precision oncology, aiming to improve the speed and accuracy of treatment selection for cancer patients, ultimately enhancing personalized care.

What Are Latest Mergers And Acquisitions In The Personalized Medicine Biomarkers Market? Renovaro And Biosymetrics Announce Merger To Accelerate AI-Driven Biomarker Discovery And Precision Medicine

In February 2025, Renovaro Inc., a US-based biotechnology company, merged with BioSymetrics Inc. to enhance AI-driven biomarker discovery and precision medicine. The merger aims to enhance drug development and create more personalized treatment strategies, addressing complex diseases through innovative, data-driven approaches. BioSymetrics Inc. is a Canada-based phenomics-driven drug discovery company integrating clinical and experimental data using machine learning to advance precision medicine.

What Is The Regional Outlook For The Global Personalized Medicine Biomarkers Market?

North America was the largest region in the personalized medicine biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized medicine biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the personalized medicine biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Personalized Medicine Biomarkers Market?

The personalized medicine biomarkers market consists of sales of biomarker-based diagnostic kits, reagents, testing platforms, epigenetic biomarkers, companion diagnostics, predictive biomarkers, prognostic biomarkers, and multi-omics biomarkers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Personalized Medicine Biomarkers Industry?

The consumer durable loans market research report is one of a series of new reports from The Business Research Company that provides consumer durable loans market statistics, including consumer durable loans industry global market size, regional shares, competitors with a consumer durable loans market share, detailed consumer durable loans market segments, market trends and opportunities, and any further data you may need to thrive in the consumer durable loans industry. The consumer durable loans market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Personalized Medicine Biomarkers Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $26.98 billion
Revenue Forecast In 2034 $51.53 billion
Growth Rate CAGR of 17.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The personalized medicine biomarkers market covered in this report is segmented –
1) By Biomarker Type: Genomic, Proteomics, Metabolic, Other Biomarker Types
2) By Disease Indication: Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, Other Indications
3) By Application: Early Detection Or Screening, Diagnosis, Treatment Selection, Monitoring
4) By End Use: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Diagnostic Labs, Other End Users Subsegments:
1) By Genomic: Single Nucleotide Polymorphisms (SNPs), Copy Number Variations (CNVs), Gene Expression Biomarkers, Epigenetic Biomarkers
2) By Proteomics: Protein Expression Biomarkers, Post-Translational Modification (PTM) Biomarkers, Protein-Protein Interaction Biomarkers, Enzyme Activity Biomarkers
3) By Metabolic: Lipid Biomarkers, Amino Acid Biomarkers, Carbohydrate Biomarkers, Hormone Biomarkers
4) By Other Biomarker Types: Inflammatory Biomarkers, Microbiome Biomarkers, Autoantibody Biomarkers, Extracellular Vesicle Biomarkers
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Request for Sample
Customization ScopeExplore Purchase Options
Pricing And Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Personalized Medicine Biomarkers Market Characteristics

    3. Personalized Medicine Biomarkers Market Trends And Strategies

    4. Personalized Medicine Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

    5. Global Personalized Medicine Biomarkers Growth Analysis And Strategic Analysis Framework

    5.1. Global Personalized Medicine Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Personalized Medicine Biomarkers Market Growth Rate Analysis

    5.4. Global Personalized Medicine Biomarkers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Personalized Medicine Biomarkers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Personalized Medicine Biomarkers Total Addressable Market (TAM)

    6. Personalized Medicine Biomarkers Market Segmentation

    6.1. Global Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Genomic

    Proteomics

    Metabolic

    Other Biomarker Types

    6.2. Global Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Oncology

    Neurology

    Diabetes

    Autoimmune Diseases

    Cardiology

    Other Indications

    6.3. Global Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Early Detection Or Screening

    Diagnosis

    Treatment Selection

    Monitoring

    6.4. Global Personalized Medicine Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals And Clinics

    Pharmaceutical And Biotechnology Companies

    Diagnostic Labs

    Other End Users

    6.5. Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Genomic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Single Nucleotide Polymorphisms (SNPs)

    Copy Number Variations (CNVs)

    Gene Expression Biomarkers

    Epigenetic Biomarkers

    6.6. Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Proteomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Protein Expression Biomarkers

    Post-Translational Modification (PTM) Biomarkers

    Protein-Protein Interaction Biomarkers

    Enzyme Activity Biomarkers

    6.7. Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Metabolic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Lipid Biomarkers

    Amino Acid Biomarkers

    Carbohydrate Biomarkers

    Hormone Biomarkers

    6.8. Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Other Biomarker Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Inflammatory Biomarkers

    Microbiome Biomarkers

    Autoantibody Biomarkers

    Extracellular Vesicle Biomarkers

    7. Personalized Medicine Biomarkers Market Regional And Country Analysis

    7.1. Global Personalized Medicine Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Personalized Medicine Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Personalized Medicine Biomarkers Market

    8.1. Asia-Pacific Personalized Medicine Biomarkers Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Personalized Medicine Biomarkers Market

    9.1. China Personalized Medicine Biomarkers Market Overview

    9.2. China Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Personalized Medicine Biomarkers Market

    10.1. India Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Personalized Medicine Biomarkers Market

    11.1. Japan Personalized Medicine Biomarkers Market Overview

    11.2. Japan Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Personalized Medicine Biomarkers Market

    12.1. Australia Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Personalized Medicine Biomarkers Market

    13.1. Indonesia Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Personalized Medicine Biomarkers Market

    14.1. South Korea Personalized Medicine Biomarkers Market Overview

    14.2. South Korea Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Personalized Medicine Biomarkers Market

    15.1. Western Europe Personalized Medicine Biomarkers Market Overview

    15.2. Western Europe Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Personalized Medicine Biomarkers Market

    16.1. UK Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Personalized Medicine Biomarkers Market

    17.1. Germany Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Personalized Medicine Biomarkers Market

    18.1. France Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Personalized Medicine Biomarkers Market

    19.1. Italy Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Personalized Medicine Biomarkers Market

    20.1. Spain Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Personalized Medicine Biomarkers Market

    21.1. Eastern Europe Personalized Medicine Biomarkers Market Overview

    21.2. Eastern Europe Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Personalized Medicine Biomarkers Market

    22.1. Russia Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Personalized Medicine Biomarkers Market

    23.1. North America Personalized Medicine Biomarkers Market Overview

    23.2. North America Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Personalized Medicine Biomarkers Market

    24.1. USA Personalized Medicine Biomarkers Market Overview

    24.2. USA Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Personalized Medicine Biomarkers Market

    25.1. Canada Personalized Medicine Biomarkers Market Overview

    25.2. Canada Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Personalized Medicine Biomarkers Market

    26.1. South America Personalized Medicine Biomarkers Market Overview

    26.2. South America Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Personalized Medicine Biomarkers Market

    27.1. Brazil Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Personalized Medicine Biomarkers Market

    28.1. Middle East Personalized Medicine Biomarkers Market Overview

    28.2. Middle East Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Personalized Medicine Biomarkers Market

    29.1. Africa Personalized Medicine Biomarkers Market Overview

    29.2. Africa Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Personalized Medicine Biomarkers Market Competitive Landscape And Company Profiles

    30.1. Personalized Medicine Biomarkers Market Competitive Landscape

    30.2. Personalized Medicine Biomarkers Market Company Profiles

    30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

    31. Personalized Medicine Biomarkers Market Other Major And Innovative Companies

    31.1. Merck KGaA

    31.2. GE Healthcare

    31.3. Laboratory Corporation of America Holdings (LabCorp)

    31.4. Agilent Technologies Inc.

    31.5. Hologic Inc.

    31.6. Illumina Inc.

    31.7. PerkinElmer Inc.

    31.8. Beckman Coulter Inc.

    31.9. Bio-Rad Laboratories Inc.

    31.10. QIAGEN N.V.

    31.11. DH Life Sciences LLC

    31.12. Myriad Genetics Inc.

    31.13. Guardant Health Inc.

    31.14. Cardiff Oncology Inc.

    31.15. 23andMe Inc.

    32. Global Personalized Medicine Biomarkers Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Personalized Medicine Biomarkers Market

    34. Recent Developments In The Personalized Medicine Biomarkers Market

    35. Personalized Medicine Biomarkers Market High Potential Countries, Segments and Strategies

    35.1 Personalized Medicine Biomarkers Market In 2029 - Countries Offering Most New Opportunities

    35.2 Personalized Medicine Biomarkers Market In 2029 - Segments Offering Most New Opportunities

    35.3 Personalized Medicine Biomarkers Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Personalized Medicine Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Genomic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Proteomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Metabolic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Other Biomarker Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Personalized Medicine Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Personalized Medicine Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: AbbVie Inc. Financial Performance
  • Table 80: Bristol-Myers Squibb Company Financial Performance
  • Table 81: Thermo Fisher Scientific Inc. Financial Performance
  • Table 82: Abbott Laboratories Financial Performance
  • Table 83: Novartis AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Personalized Medicine Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Genomic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Proteomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Metabolic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Other Biomarker Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Personalized Medicine Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Personalized Medicine Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: AbbVie Inc. Financial Performance
  • Figure 80: Bristol-Myers Squibb Company Financial Performance
  • Figure 81: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 82: Abbott Laboratories Financial Performance
  • Figure 83: Novartis AG Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Personalized Medicine Biomarkers market?

Personalized medicine biomarkers are specific biological indicators that tailor medical treatments to individual patients based on their unique genetic, molecular, or physiological characteristics. These biomarkers can help predict how a patient will respond to a particular drug, enabling doctors to choose the most effective and safest treatment options. For further insights on the Personalized Medicine Biomarkers market, request a sample here

How will the Personalized Medicine Biomarkers market drivers and restraints affect the market dynamics? What forces will shape the Personalized Medicine Biomarkers industry going forward?

The Personalized Medicine Biomarkers market major growth driver - Rising Prevalence Of Chronic Diseases Driving Growth Of The Market Due To Increasing Need For Targeted Treatments And Precision Diagnostics. For further insights on the Personalized Medicine Biomarkers market, request a sample here

What is the forecast market size or the forecast market value of the Personalized Medicine Biomarkers market?

The Personalized Medicine Biomarkers market size has grown strongly in recent years. The personalized medicine biomarkers market size has grown rapidly in recent years. It will grow from $22.85 billion in 2024 to $26.98 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, rising adoption of companion diagnostics, growing investment in biomarker research, rising focus on early diagnosis and preventive healthcare, and regulatory support for biomarker-based therapies. The personalized medicine biomarkers market size is expected to see rapid growth in the next few years. It will grow to $51.53 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to expanding applications in precision oncology, increasing demand for targeted therapies, growing focus on early disease detection, growing consumer demand for personalized approaches, and supportive government policies and funding. Major trends in the forecast period include a multi-omics approach for biomarker identification, development of liquid biopsy-based biomarkers, increasing use of digital biomarkers, adoption of AI and machine learning in biomarker discovery, and expansion of real-world evidence in biomarker validation. For further insights on the Personalized Medicine Biomarkers market, request a sample here

How is the Personalized Medicine Biomarkers market segmented?

The personalized medicine biomarkers market covered in this report is segmented –
1) By Biomarker Type: Genomic, Proteomics, Metabolic, Other Biomarker Types
2) By Disease Indication: Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, Other Indications
3) By Application: Early Detection Or Screening, Diagnosis, Treatment Selection, Monitoring
4) By End Use: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Diagnostic Labs, Other End Users

Subsegments:
1) By Genomic: Single Nucleotide Polymorphisms (SNPs), Copy Number Variations (CNVs), Gene Expression Biomarkers, Epigenetic Biomarkers
2) By Proteomics: Protein Expression Biomarkers, Post-Translational Modification (PTM) Biomarkers, Protein-Protein Interaction Biomarkers, Enzyme Activity Biomarkers
3) By Metabolic: Lipid Biomarkers, Amino Acid Biomarkers, Carbohydrate Biomarkers, Hormone Biomarkers
4) By Other Biomarker Types: Inflammatory Biomarkers, Microbiome Biomarkers, Autoantibody Biomarkers, Extracellular Vesicle Biomarkers For further insights on the Personalized Medicine Biomarkers market,
request a sample here

Which region has the largest share of the Personalized Medicine Biomarkers market? What are the other regions covered in the report?

Major companies operating in the personalized medicine biomarkers market are AbbVie Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Merck KGaA, GE Healthcare, Laboratory Corporation of America Holdings (LabCorp), Agilent Technologies Inc., Hologic Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., DH Life Sciences LLC, Myriad Genetics Inc., Guardant Health Inc., Cardiff Oncology Inc., 23andMe Inc., Coriell Life Sciences Inc. For further insights on the Personalized Medicine Biomarkers market, request a sample here.

Who are the major players in the Personalized Medicine Biomarkers market?

. For further insights on the Personalized Medicine Biomarkers market, request a sample here.

What are the key trends in the Personalized Medicine Biomarkers market?

Major trends in the Personalized Medicine Biomarkers market include North America was the largest region in the personalized medicine biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized medicine biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.. For further insights on the Personalized Medicine Biomarkers market, request a sample here.

What are the major opportunities in the Personalized Medicine Biomarkers market? What are the strategies for the Personalized Medicine Biomarkers market?

For detailed insights on the major opportunities and strategies in the Personalized Medicine Biomarkers market, request a sample here.

How does the Personalized Medicine Biomarkers market relate to the overall economy and other similar markets?

For detailed insights on Personalized Medicine Biomarkers's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Personalized Medicine Biomarkers industry?

For detailed insights on the mergers and acquisitions in the Personalized Medicine Biomarkers industry, request a sample here.

What are the key dynamics influencing the Personalized Medicine Biomarkers market growth? SWOT analysis of the Personalized Medicine Biomarkers market.

For detailed insights on the key dynamics influencing the Personalized Medicine Biomarkers market growth and SWOT analysis of the Personalized Medicine Biomarkers industry, request a sample here.